Peer-reviewedCC BYBiomedicines
Antitumor Activity of a Bupleurum chinense-Derived Vesicle-like Particle Preparation in MOC1 Oral Squamous Cell Carcinoma Models
Related
- c-MET Inhibition Is Accompanied by PD-L1 Upregulation and Immunosuppression-Related Tumor Microenvironment Changes in Esophageal Squamous Cell Carcinoma, With Enhanced Antitumor Activity in Combination With Anti-PD-1 Therapy.
- NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trial
- Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity
- CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells
- 318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer
BibTeX
@article{anon2026antitumor,
title = {{Antitumor Activity of a Bupleurum chinense-Derived Vesicle-like Particle Preparation in MOC1 Oral Squamous Cell Carcinoma Models}},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701900},
note = {CC BY},
}
RIS
TY - JOUR
TI - Antitumor Activity of a Bupleurum chinense-Derived Vesicle-like Particle Preparation in MOC1 Oral Squamous Cell Carcinoma Models
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701900
SN - 2227-9059
ER -